pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

7,939 catalysts · 5,063 phase readout · 2,308 8k filing · 316 pdufa · 271 earnings · 108 phase 2 completion · 50 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 0 catalysts2026-10-22: 1 catalyst2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type
  • phase readout5,063
  • 8k filing2,308
  • pdufa316
  • earnings271
  • phase 2 completion108
  • phase 1 completion50
  • phase 1 2 completion28
  • phase 1 initiation22
  • phase 0 trial completion21
  • phase 1 2 initiation9
  • therapy area
    • Oncology87
    • Cardiology23
    • Immunology15
    • Infectious Disease12
    • Dermatology12
    • Ophthalmology8
    • Women's Health8
    • Pulmonology8
    • Pain6

    Date TBD

    50
    ›RECRUITINGphase readoutNCT07555561: Autologous CD19-CD20-NKG2D-nsBicephali CAR-T for Relapsed/Refractory Central Nervous System Lymphoma

    Sponsor: Beijing Boren Hospital. Phase: PHASE1. Conditions: Relapsed/Refractory Central Nervous System Lymphoma, Relapsed/Refractory Primary Central Nervous System Lymphoma, Relapsed/Refractory Secondary Central Nervous System Lymphoma

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07476742: Effect of Transcutaneous Auricular Vagus Nerve Stimulation on Postoperative Delirium and Negative Emotions in Patients Undergoing Cardiac Surgery

    Sponsor: Chinese PLA General Hospital. Phase: NA. Conditions: Postoperative Delirium (POD), Postoperative, Anxiety, Depression, Cardiac Surgical Procedures

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07479342: The Effect of Modern Teaching Method: Gamification in Orthodontics

    Sponsor: Foundation University Islamabad. Phase: NA. Conditions: Gamification in Health Education

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07558642: Effects of Stellate Ganglion Block on Delirium and Circadian Rhythm in Geriatric Intensive Care Patients

    Sponsor: Antalya Training and Research Hospital. Phase: NA. Conditions: Stellate Ganglion Block

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05610527: Hormonal Influences on Inflammatory Bowel Diseases

    Sponsor: University of Utah. Phase: . Conditions: Inflammatory Bowel Diseases, Contraception, Menstrual Problem

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07027527: An Active Comparator Safety Study Evaluating the Combination of APG777 + APG990 in Moderate-to-Severe Atopic Dermatitis

    Sponsor: Apogee Therapeutics, Inc.. Phase: PHASE1. Conditions: Atopic Dermatitis

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07526688: Aerobic Physical Activity and Orofacial Myofascial Pain

    Sponsor: University Hospital, Brest. Phase: NA. Conditions: Temporomandibular Disorders (TMD)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07181161: Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer

    Sponsor: AstraZeneca. Phase: PHASE1. Conditions: Metastatic Prostate Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07404761: Safety and Effectiveness of Spatial StimelMD (SSMD) in Subjects With Upper Limb Neuromotor Impairments

    Sponsor: Motion Informatics LTD. Phase: NA. Conditions: Stroke, Upper-limb Motor Impairment, Hemiparesis, Spinal Cord Injury, Traumatic Brain Injury

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT04214561: Relationship Between Selected Parameters and Bruxism

    Sponsor: Wroclaw Medical University. Phase: . Conditions: Sleep Bruxism, Sleep Disorder, Psychosomatic Disorder, Pain, Anxiety, Mental Status Change, Temporomandibular Disorder

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT05468203: PREVENTion With Sglt-2 Inhibition of Acute Kidney Injury in Intensive Care

    Sponsor: The George Institute. Phase: PHASE3. Conditions: Acute Kidney Injury

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07437703: Labour Pain Relief Options: Video Versus Pamphlet for Easing Fear of Birth and Improving Preparedness in Pregnant Patients, an RCT

    Sponsor: Fraser Health. Phase: NA. Conditions: Labour Pain

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06152627: Voice Therapy Per the Rehabilitation Treatment Specification System

    Sponsor: Massachusetts General Hospital. Phase: . Conditions: Muscle Tension Dysphonia

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04953442: Fit 24 Technology Intervention YOUTH

    Sponsor: Baylor College of Medicine. Phase: NA. Conditions: Diabetes Mellitus, Type 2

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT05202288: Impact of Delay Between Administration of Inmazeb Administration and Vaccination by Ervebo on Vaccine Immune Response on Healthy Volunteers

    Sponsor: ANRS, Emerging Infectious Diseases. Phase: PHASE2. Conditions: Ebola Virus Disease

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07557888: A Prospective Clinical Study on the Efficacy and Safety of Bacterial Lysate (OM-85) Combined With Antihistamines in the Treatment of Chronic Spontaneous Urticaria (CSU): A Single-Centre, Observational, Cohort Study

    Sponsor: The Fourth Affiliated Hospital of Zhejiang University School of Medicine. Phase: . Conditions: Chronic Spontaneous Urticaria (CSU)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07052903: TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

    Sponsor: Alnylam Pharmaceuticals. Phase: PHASE3. Conditions: Transthyretin Amyloidosis With Cardiomyopathy

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04027868: Genomic BRCA and Extensive ovArian Cancer Testing

    Sponsor: ARCAGY/ GINECO GROUP. Phase: . Conditions: Epithelial Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05855668: Phenotyping Patients With Alcohol and Cannabis Use Disorders Using the Addictions Neuroclinical Assessment

    Sponsor: Centre for Addiction and Mental Health. Phase: NA. Conditions: Alcohol Use Disorder, Cannabis Use Disorder

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03883217: Optimizing Vibrational Therapy to Improve Gait and Balance in Parkinson's Disease

    Sponsor: Virginia Commonwealth University. Phase: NA. Conditions: Parkinson Disease

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03048240: INtraoperative photoDYnamic Therapy of GliOblastoma

    Sponsor: University Hospital, Lille. Phase: NA. Conditions: Glioblastoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06479174: Cognitive Strategies for Optimizing Brain Health And Managing Transgenerational Vascular Risk Factors Post-Stroke

    Sponsor: University of New Mexico. Phase: NA. Conditions: Stroke, Ischemic

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07242118: Conformal Ablative Radiotherapy in Older Women (CARMEN) With Breast Cancer Undergoing Non-Operative Management

    Sponsor: University of Kansas Medical Center. Phase: NA. Conditions: Breast Cancer Female

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05565118: Prospective Surgical Study on the Pattern of Electrical Activity in High Grade Glioma as a Predictor of Progression

    Sponsor: Case Comprehensive Cancer Center. Phase: PHASE1. Conditions: High Grade Glioma, Glioblastoma

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT02489318: A Study of Apalutamide (JNJ-56021927, ARN-509) Plus Androgen Deprivation Therapy (ADT) Versus ADT in Participants With mHSPC

    Sponsor: Aragon Pharmaceuticals, Inc.. Phase: PHASE3. Conditions: Prostate Cancer

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07266090: A Study to Evaluate the Safety,Tolerability,Pharmacokinetics and Pharmacodynamics of Cenerimod in Adult Chinese Participants With Moderate-to-severe Systemic Lupus Erythematosus (SLE)

    Sponsor: Viatris Pharmaceuticals Co., Ltd.. Phase: PHASE2. Conditions: SLE - Systemic Lupus Erythematosus

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT03875690: Benefit of a Flash Dose of Corticosteroids in Digestive Surgical Oncology: a Randomized, Double Blind, Placebo-controlled Trial

    Sponsor: Centre Hospitalier Universitaire Dijon. Phase: PHASE3. Conditions: Elective Surgery for Any Digestive Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04879290: Comparison of Two FiO2 (1 or 0.5) for Tracheal Extubation in Post-anesthesia Care Unit

    Sponsor: University Hospital, Caen. Phase: NA. Conditions: Anesthesia, Atelectasis, Postoperative Complications, Hypoxemia, Hyperoxia

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05085210: Improving Visual Field Deficits With Noninvasive Brain Stimulation

    Sponsor: Beth Israel Deaconess Medical Center. Phase: NA. Conditions: Visual Field Defect, Peripheral, Stroke, Visual Impairment, Hemianopsia, Quadrantanopia, Cortical Blindness, Visual Field Defect Homonymous Bilateral, Occipital Lobe Infarct, Visual Fields Hemianopsia

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06251310: SW-682 in Advanced Solid Tumors

    Sponsor: SpringWorks Therapeutics, Inc.. Phase: PHASE1. Conditions: Advanced Solid Tumor, Mesothelioma, Malignant

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06633913: Concurrent TMS-fMRI

    Sponsor: Jing Jiang. Phase: NA. Conditions: Healthy Control, Depression

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06368323: Effect of Community Choir Singing in People With Chronic Post-stroke Aphasia

    Sponsor: University of Ottawa. Phase: NA. Conditions: Aphasia

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03391323: Medacta GMK Sphere® vs. Medacta GMK PS Post-Market Outcomes Study

    Sponsor: David F. Scott, MD. Phase: NA. Conditions: Osteoarthritis, Osteoarthritis, Knee, Joint Disease

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06795659: Combining Esketamine and Prolonged Exposure Treatment for PTSD (Post Traumatic Stress Disorder)

    Sponsor: The University of Texas Health Science Center at San Antonio. Phase: PHASE1. Conditions: Post Traumatic Stress Disorder PTSD

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05051059: Assessment of the Functional Outcome and Quality of Life in Sarcoma Patients

    Sponsor: Universitaire Ziekenhuizen KU Leuven. Phase: NA. Conditions: Soft Tissue Sarcoma, Bone Sarcoma

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT02400359: Lorcaserin in Obesity: Identification of CNS Targets Using fMRI

    Sponsor: Beth Israel Deaconess Medical Center. Phase: PHASE4. Conditions: Obesity, Weight Loss

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05758480: Characterization of the Immunometabolic Signature in Long COVID-19.

    Sponsor: University Hospital, Angers. Phase: NA. Conditions: Long COVID

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07402096: Effect of a Mindfulness-Based Stress Reduction Program on Hot Flashes and Sleep Quality in Menopausal Women: A Randomized Controlled Trial

    Sponsor: Inonu University. Phase: NA. Conditions: Menopause, Hot Flashes, Sleep Wake Disorders

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07156162: Effectiveness of Taste vs. Health-Based Messaging to Improve Diet Quality

    Sponsor: Penn State University. Phase: NA. Conditions: Behavior, Health

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07539662: Unrelated Umbilical Cord Blood Transplantation for the Treatment of Amyotrophic Lateral Sclerosis (ALS)

    Sponsor: Institute of Hematology & Blood Diseases Hospital, China. Phase: NA. Conditions: ALS (Amyotrophic Lateral Sclerosis)

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT02886546: Utility of Dynamic Variables Measured by Calibrated Pulse Contour Analysis of Oesophageal Doppler Monitor for Predicting Fluid Responsiveness During Robot-Assisted Laparoscopic Prostatectomy

    Sponsor: Hallym University Kangnam Sacred Heart Hospital. Phase: NA. Conditions: Prostate Cancer

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07444346: Intravascular Imaging-Guided Intravascular Lithotripsy for Severe Coronary Calcified Lesions.

    Sponsor: The First Affiliated Hospital with Nanjing Medical University. Phase: . Conditions: Coronary Artery Calcification, Coronary Artery Disease

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07116746: Evaluation of Efficacy and Safety of AR882 and XOI Co-administration in Uricase Treatment Failed Patients

    Sponsor: Arthrosi Therapeutics. Phase: PHASE2. Conditions: Gout, Gouty Arthritis, Hyperuricemia, Gout Chronic, Refractory Gout, Uncontrolled Gout, Tophaceous Gout

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07479303: Vitamin D Status in Young Medical Residents

    Sponsor: Maimónides Biomedical Research Institute of Córdoba. Phase: . Conditions: Vitamin D Deficiency

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06335303: A Study to Test Whether BI 1819479 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)

    Sponsor: Boehringer Ingelheim. Phase: PHASE2. Conditions: Idiopathic Pulmonary Fibrosis

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT05268003: A Phase II Study of the Combination of Ponatinib With Mini-hyper CVD Chemotherapy and Venetoclax in Patients With Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia

    Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Acute Lymphoblastic Leukemia, Leukemia

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07455227: ERCP Management in Mild Gallstone-Induced Pancreatitis Patients Declining Subsequent Cholecystectomy : a Randomized Control Trial.

    Sponsor: Fu Jen Catholic University Hospital. Phase: NA. Conditions: Pancreatitis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03586427: Zelquistinel in the Treatment of Major Depressive Disorder

    Sponsor: Syndeio Biosciences, Inc. Phase: PHASE2. Conditions: Depressive Disorder, Major

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT01453127: DaTSCAN Imaging in Aging and Neurodegenerative Disease

    Sponsor: Mayo Clinic. Phase: PHASE4. Conditions: Dementia, Parkinsonism, Mild Cognitive Impairment, REM Sleep Behavior Disorder

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT04318327: BCMA-directed CAR-T Cell Therapy in Adult Patients With Multiple Myeloma

    Sponsor: Novartis Pharmaceuticals. Phase: PHASE1. Conditions: Multiple Myeloma

    full page →ctgov ↗
    ← prev
    page 71 of 159
    next →